Mode
Text Size
Log in / Sign up
N/A N=80 Randomized Double-blind Prevention

Free Time For Wellness Pilot Effectiveness Trial

Physical Inactivity

Enrolled (actual)
80
Serious AEs
0.0%
Results posted
Nov 2025
Primary outcome: Primary: Total Minutes of Time Spent in Moderate to Vigorous Physical Activity (MVPA) — 548; 512; 354; 737 minutes of MVPA per week

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Arms (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Columbia University
Primary completion
Oct 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
Total Minutes of Time Spent in Moderate to Vigorous Physical Activity (MVPA)
548; 512; 354; 737; 479; 404
SECONDARY
EQ5D-5L Score
0.86; 0.89; 0.90; 0.87; 0.91; 0.92
SECONDARY
ICEpop CAPability Measure for Adults (ICECAP-A) Score
0.39; 0.36; 0.44; 0.41; 0.32; 0.34
SECONDARY
Attendance
0.13; 0.19; 0.22
SECONDARY
Generalized Anxiety Disorder 2-item (GAD-2) Score
1.6; 1.6; 1.5; 1.8; 1.3; 1.4
SECONDARY
Patient Health Questionnaire-2 (PHQ-2)
1.1; 1.3; 1.7; 1.2; 1.2; 1.3
SECONDARY
International Physical Activity Questionnaire (IPAQ) Score
3065; 2840; 2449; 2652; 2054; 2088

Summary

Physical inactivity is pervasive and prevalent in the United States, particularly among women of low socioeconomic position, and women with children. Structural and social barriers make active leisure time a rare commodity creating a pressing health issue because physical inactivity increases the risk of chronic diseases and poor health. The broad objective of this study is to pilot test the Free Time for Wellness (FT4W), an innovative multilevel physical activity intervention to increase physical activity among low-resourced mothers.

Eligibility Criteria

Inclusion Criteria

  • Understand/speak English or Spanish
  • Have children <12 years old
  • Own a mobile phone
  • Live in the zip code surrounding as Shape Up NYC sites

Exclusion Criteria

  • Total household income being greater than 165% of the area median income (calculated by household size).
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT06474715). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search